Taken together, our data provide further insights into the mechanisms of action of the mouse-selective STING agonist DMXAA in human cells and suggest that DMXAA derivatives such as HHMX are potential therapeutic agents for STING-associated autoinflammatory diseases, including SAVI. The gene discussed is STING1; the disease is STING-associated vasculopathy with onset in infancy.